Skip to main content

Want a detailed portfolio tracker?

INBS
NASDAQ
$1.97

Intelligent Bio Solutions Inc (INBS)

Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven technologies, specifically designed for drug abuse testing and monitoring. Utilizing advanced scientific methodologies, INBS offers rapid and precise testing options that enhance clinical decision-making processes and improve patient outcomes. In a healthcare landscape increasingly reliant on innovative diagnostic tools, INBS is well-positioned to make substantial contributions to this evolving field, reinforcing its dedication to advancing healthcare quality and operational effectiveness.
Website: https://ibs.inc
Target: $12 (+509.14%)

Market Cap

$4.58M

P/B Ratio

0.60

Revenue 5Y CAGR

+60.04%

Beta (5Y)

1.19

Price Chart

Valuation
Market Cap$4.58M
P/S1.40
P/B0.60
Profitability
Total Revenue (TTM)$3.91M
Gross Profit (TTM)$1.85M
EBITDA-$11M
Profit Margin-296.8%
Operating Margin-277.3%
EPS-$11.09
Growth & Risk
Revenue 5Y CAGR+60.04%
FCF 5Y CAGR+2.84%
Beta (5Y)1.19
Sharpe Ratio-0.74